INS and type 2 diabetes mellitus: This high palmitoleic acid improved insulin sensitivity among type 2 diabetes mellitus patients [123] and prevented reduced insulin sensitivity in non-diabetic individuals [124], which adversely support the finding from patients with high levels of HOMA2-%S [44].